Bax-inhibiting peptides derived from Ku70 and cell-penetrating pentapeptides

被引:79
作者
Gomez, J. A.
Gama, V.
Yoshida, T.
Sun, W.
Hayes, P.
Leskovll, K.
Boothman, D.
Matsuyama, S. [1 ]
机构
[1] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA
[2] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Reprod, Sendai, Miyagi 980, Japan
[3] Sankyo Pharmaceut Co Ltd, Tokyo, Japan
[4] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA
[5] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA
[6] Univ Texas, SW Med Ctr, Dept Pharmacol, Program Cell Stress & Canc Nanomed, Dallas, TX 75390 USA
[7] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Div Hematol & Oncol, Cleveland, OH 44106 USA
关键词
bax-inhibiting peptide (SIP); cell-penetrating peptide (CPP); drug delivery; pentapelptide;
D O I
10.1042/BST0350797
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We found that Ku70, a known DNA repair factor, has a novel function to bind and inhibit Bax (Bcl-2-associated X protein), a key mediator of apoptosis. Pentapeptides derived from the Bax-binding domain of Ku70 were cell-permeable and protected cells from Bax-mediated apoptosis. These pentapeptides were called BIPs (Bax-inhibiting peptides). BIPs may become a useful therapeutic tool to reduce cellular damage. We also generated BIP mutant pentapeptides that do not inhibit Bax, but retain their cell-penetrating activity. Since both BIPs and BIP mutants are cell-permeable, these peptides were designated CPP5s (cell-penetrating pentapeptides). Among the CPP5s discovered, VPTLK (BIP) and KLPVM (BIP mutant) were confirmed to possess protein transduction activity by examination of the delivery of GFP (green fluorescent protein) into cells by these peptides. The mechanism of cell penetration by CPP5s is not known. CPP5s enter the cell at 0 and 4 degrees C. In preliminary studies, various inhibitors of endocytosis and pinocytosis did not show any significant suppression of UPS cell entry. CPP5s have very low toxicity in vitro and in vivo and so may be useful tools in order to develop non-toxic drug-delivery technologies.
引用
收藏
页码:797 / 801
页数:5
相关论文
共 39 条
[1]   The kinetics and tissue distribution of protein transduction in mice [J].
Cai, SR ;
Xu, G ;
Becker-Hapak, M ;
Ma, M ;
Dowdy, SF ;
McLeod, HL .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 27 (04) :311-319
[2]   Hypoxia-induced retinal ganglion cell death and the neuroprotective effects of beta-adrenergic antagonists [J].
Chen, Yi-Ning ;
Yamada, Hideyuki ;
Mao, Wei ;
Matsuyama, Shigemi ;
Aihara, Makoto ;
Araie, Makoto .
BRAIN RESEARCH, 2007, 1148 :28-37
[3]   Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase [J].
Cohen, HY ;
Miller, C ;
Bitterman, KJ ;
Wall, NR ;
Hekking, B ;
Kessler, B ;
Howitz, KT ;
Gorospe, M ;
de Cabo, R ;
Sinclair, DA .
SCIENCE, 2004, 305 (5682) :390-392
[4]   Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis [J].
Cohen, HY ;
Lavu, S ;
Bitterman, KJ ;
Hekking, B ;
Imahiyerobo, TA ;
Miller, C ;
Frye, R ;
Ploegh, H ;
Kessler, BM ;
Sinclair, DA .
MOLECULAR CELL, 2004, 13 (05) :627-638
[5]   DNA repair: How Ku makes ends meet [J].
Doherty, AJ ;
Jackson, SR .
CURRENT BIOLOGY, 2001, 11 (22) :R920-R924
[6]   A means to a DNA end: The many roles of Ku [J].
Downs, JA ;
Jackson, SP .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (05) :367-378
[7]   Cell-penetrating peptides:: Mechanisms and applications [J].
El-Andaloussi, S ;
Holm, T ;
Langel, Ü .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (28) :3597-3611
[8]   CELLULAR UPTAKE OF THE TAT PROTEIN FROM HUMAN IMMUNODEFICIENCY VIRUS [J].
FRANKEL, AD ;
PABO, CO .
CELL, 1988, 55 (06) :1189-1193
[9]   Membrane permeability commonly shared among arginine-rich peptides [J].
Futaki, S ;
Goto, S ;
Sugiura, Y .
JOURNAL OF MOLECULAR RECOGNITION, 2003, 16 (05) :260-264
[10]   Membrane-permeable arginine-rich peptides and the translocation mechanisms [J].
Futaki, S .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (04) :547-558